On the Record · Revvity
Revvity competitors, on the record
The companies whose own annual reports name Revvity as a competitor, each with the sentence it appears in and the filing it came from.
Who Revvity names
Revvity’s annual reports for 2023 to 2025 describe its competition by kind of business and do not name competing companies.
Who names Revvity
Companies whose own annual reports name Revvity as a competitor.
Word for word“Our competitors in the NIPT space include BGI; BillionToOne Inc.; Fulgent Genetics; Illumina, through its subsidiary Verinata; Laboratory Corporation of America Holdings, or Labcorp; Myriad Genetics, Inc.; Quest Diagnostics Incorporated, or Quest; and Revvity Inc.” 10-K for 2025
Word for word“Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Waters Corporation (acquired BD Diagnostics division) and Wermerson Immuncor.” 10-K for 2025
Word for word“The Company’s principal competitors in the service market include Revvity, Inc., Agilent Technologies, Inc. and Thermo Fisher Scientific Inc.” 10-K for 2025
Read from Revvity’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.